US Patent Issued to CG Pharmaceuticals on Feb. 17 for "Ivaltinostat combination therapy for treating pancreatic cancer" (South Korean, American Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,553,903, issued on Feb. 17, was assigned to CG Pharmaceuticals Inc (Orinda, Calif.).

"Ivaltinostat combination therapy for treating pancreatic cancer" was invented by Sangsook Cho (Moraga, Calif.) and Joong Myung Cho (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the present disclosure relates to ivaltinostat combination therapy for treating pancreatic cancer in subjects having low levels of serological protein biomarkers with negative correlation to progression-free survival (PFS)."

The patent was filed on May 7, 2024, under Application No. 18/657,510.

*For further information, including images, charts and tables, p...